Abstract:Colorectal cancer (CRC) is one of the most common malignancies worldwide. The 5‐year survival rate of patients diagnosed with the early stages of the disease is markedly higher than that of patients in the advanced stages. Therefore, identifying novel biomarkers and drug targets for CRC is critical for clinical practice. Zinc finger protein 169 (ZNF169) is a crucial transcription factor, and its role in CRC remains to be explored. The present study aimed to investigate the clinical relevance, function and underlying mechanisms of ZNF169 in CRC growth and proliferation. The Cancer Genome Atlas (TCGA) database was utilized to analyze the clinical relevance of ZNF169 in patients with CRC. Immunohistochemical staining was performed on tissue samples from patients with CRC to detect the expression of ZNF169. The HCT‐116, HT‐29 and RKO cell lines were employed for in vitro experiments. The overexpression and knockdown of ZNF169 were achieved by transfecting the cells with lentivirus and small interfering RNAs, respectively. Cell Counting Kit‐8, colony formation and EdU staining assays were applied to investigate the function of ZNF169 in CRC cells. Dual luciferase activity and chromatin immunoprecipitation (ChIP)‐quantitative PCR (qPCR) assays were performed to identify the regulatory effects of ZNF169 on the ankyrin repeat and zinc‐finger domain‐containing 1 (ANKZF1; also known as ZNF744) gene. Reverse transcription‐quantitative PCR and western blot analysis were performed to measure mRNA and protein expression, respectively. The analysis of TCGA data revealed a positive correlation between ZNF169 and ANKZF1, with the overexpression of ANKZF1 being associated with a poor prognosis of patients with CRC. The experimental results demonstrated that ZNF169 was expression upregulated in CRC tissue compared with that in normal colon tissue. Gain‐of‐function and loss‐of‐function experiments revealed that ZNF169 enhanced the intensity of EdU staining, promoting the growth and proliferation of CRC cells. Furthermore, the overexpression of ZNF169 potentiated the transcriptional activity of the ANKZF1 gene, while the knockdown of ZNF169 produced the opposite results. ChIP‐qPCR confirmed the interaction between ZNF169 and the promoter sequence of ANKZF1. Rescue experiments revealed that ZNF169 accelerated CRC cell growth and proliferation through the upregulation of ANKZF1. Furthermore, there was a positive correlation identified between ZNF169 and ANKZF1, and upregulation of ANKZF1 expression was associated with the poor prognosis of patients with CRC. On the whole, the present study demonstrates that ZNF169 contributes to CRC malignancy by potentiating the expression of ANKZF1. Thus, the regulation of ZNF169 and/or ANKZF1 expression may represent a viable strategy for the treatment patients with CRC with a high expression of ZNF169.

High expression of Zinc-finger protein X-linked promotes tumor growth and predicts a poor outcome for stage II/III colorectal cancer patients.

Zinc-finger Protein X-linked is a Novel Predictor of Prognosis in Patients with Colorectal Cancer.

Zinc Finger X-chromosomal Protein (ZFX) is a Significant Prognostic Indicator and Promotes Cellular Malignant Potential in Gallbladder Cancer.

Zinc Finger Protein X-Linked (ZFX) Contributes to Patient Prognosis, Cell Proliferation and Apoptosis in Human Laryngeal Squamous Cell Carcinoma.

ZFX promotes tumorigenesis and confers chemotherapy resistance in esophageal squamous cell carcinoma

ZNF418 Overexpression Protects Against Gastric Carcinoma and Prompts a Good Prognosis

Knockdown of ZFX Inhibits Gastric Cancer Cell Growth in Vitro and in Vivo Via Downregulating the ERK-MAPK Pathway.

High expression of Zinc-finger protein X-linked is associated with reduced E-cadherin expression and unfavorable prognosis in nasopharyngeal carcinoma.

Cuproptosis-Related Gene FDX1 Suppresses the Growth and Progression of Colorectal Cancer by Retarding EMT Progress

Zyxin As a Potential Cancer Prognostic Marker Promotes the Proliferation and Metastasis of Colorectal Cancer Cells.

Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1

ZFX Promotes Proliferation and Metastasis of Pancreatic Cancer Cells via the MAPK Pathway

Activation of FXR and Inhibition of EZH2 Synergistically Inhibit Colorectal Cancer Through Cooperatively Accelerating FXR Nuclear Location and Upregulating CDX2 Expression.

Expression of ZNF148 in Different Developing Stages of Colorectal Cancer and Its Prognostic Value

Knockdown of Zinc Finger Protein X-linked Inhibits Prostate Cancer Cell Proliferation and Induces Apoptosis by Activating Caspase-3 and Caspase-9

ZFX knockdown inhibits growth and migration of non-small cell lung carcinoma cell line H1299.

Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma

The E3 ubiquitin ligase SCF (FBXW10)-mediated LATS2 degradation regulates angiogenesis and liver metastasis in colorectal cancer

Overexpression of ZNF460 Predicts Worse Survival and Promotes Metastasis Through JAK2/STAT3 Signaling Pathway in Patient with Colon Cancer

An Analysis Regarding the Association Between DAZ Interacting Zinc Finger Protein 1 (DZIP1) and Colorectal Cancer (CRC)

Regulation of Cell Proliferation and Migration in Gallbladder Cancer by Zinc Finger X-chromosomal Protein